Clinical Trial

A Study of PLB-002 in Advanced Solid Tumors

Name: A Study of PLB-002 in Advanced Solid Tumors — clinical trial record (NCT07304128)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study will test the safety, including side effects, and determine the characteristics of a drug called PLB-002 in participants with solid tumors.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-11.

Status change: Not Yet Recruiting → Recruiting 2026-02-27

Trial Details

NCT Number	NCT07304128
Lead Sponsor	Primelink BioTherapeitics(ShenZhen) Limited
Conditions	Advanced Solid Tumor
Enrollment	100 participants
Start Date	2026-02-06
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-03